Welcome to CDC stacks | Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009 - 18400 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009
  • Published Date:
    Mar 2011
  • Source:
    Emerg Infect Dis. 17(3):566-567.
Filetype[PDF-94.68 KB]


No Related Documents.
You May Also Like:
  1. Diagnosis and Treatment of Tuberculosis in the Private Sector, Vietnam
    Personal Author:
    Hoa, Nguyen B.; Cobelens, Frank G.J.; Sy, Dinh N.; Nhung, Nguyen V.; Borgdorff, Martien W.; Tiemersma, Edine W.;
    Published:
    Mar 2011
    Source:
    Emerg Infect Dis. 17(3):562-566.
    File Type:
    Filetype[PDF - 101.37 KB]
  2. Enteric fever treatment failures: a global concern.
    Personal Author:
    Chandel, D. S.; Chaudhry, R.;
    Published:
    2001 Jul-Aug
    Source:
    Emerg Infect Dis. 7(4):762-763.
    File Type:
    Filetype[PDF - 40.91 KB]
  3. New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
    Personal Author:
    Malik, Seidu; Willby, Melisa; Sikes, David; Tsodikov, Oleg V.; Posey, James E.;
    Published:
    Jun 28 2012
    Source:
    PLoS One. 2012; 7(6).
    Description:
    Fluoroquinolone antibiotics are among the most potent second-line drugs used for treatment of multidrug-resistant tuberculosis (MDR TB), and resistance to this class of antibiotics is one criterion for defining extensively drug resistant tuberculosis...
    File Type:
    Filetype[PDF - 407.03 KB]
  4. Hepatitis A Associated with Semidried Tomatoes, France, 2010
    Personal Author:
    Gallot, Céline; Grout, Lise; Roque-Afonso, Anne-Marie; Couturier, Elisabeth; Carrillo-Santisteve, Paloma; Pouey, Jérôme; Letort, Marie-José; Hoppe, Stéphanie; Capdepon, Pascal; Saint-Martin, Sylvie; De Valk, Henriette; Vaillant, Véronique;
    Published:
    Mar 2011
    Source:
    Emerg Infect Dis. 17(3):566-567.
    File Type:
    Filetype[PDF - 88.14 KB]
  5. Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005–2010
    Personal Author:
    Smith, Sarah E.; Ershova, Julia; Vlasova, Natalia; Nikishova, Elena; Tarasova, Irina; Eliseev, Platon; Maryandyshev, Andrey O.; Shemyakin, Igor G.; Kurbatova, Ekaterina; Cegielski, J. Peter;
    Published:
    Jun 2015
    Source:
    Emerg Infect Dis. 21(6):1002-1011.
    Description:
    Acquired resistance to antituberculosis drugs decreases effective treatment options and the likelihood of treatment success. We identified risk factors for acquisition of drug resistance during treatment for multidrug-resistant tuberculosis (MDR TB) ...
    File Type:
    Filetype[PDF - 2.09 MB]